iBio (IBIO) Other Non Operating Income (2010 - 2021)
iBio (IBIO) posted quarterly Other Non Operating Income of $6000.0 for Q4 2021, up 100.0% quarter-over-quarter from $3000.0 in Q1 2014.
iBio (IBIO) Other Non Operating Income (2010 - 2021) Analysis & Trends
iBio (IBIO) has reported Other Non Operating Income for 6 consecutive years, with $6000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Other Non Operating Income changed N/A year-over-year to $6000.0; the TTM figure through Jun 2022 stood at $6000.0 (changed N/A YoY), while the FY2022 annual figure was $6000.0, changed N/A from the prior year.
- Other Non Operating Income grew to $6000.0 in Q4 2021 per IBIO's latest filing, from $3000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $6000.0 in Q4 2021 and bottomed at $6000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 6,000.00 |
| Mar 31, 2014 | 3,000.00 |
| Jun 30, 2013 | -4,000.00 |
| Dec 31, 2012 | 635,000.00 |
| Sep 30, 2012 | -241,000.00 |
| Jun 30, 2012 | 795,168.00 |
| Mar 31, 2012 | -918,428.00 |
| Dec 31, 2011 | -1.09 Mn |
| Sep 30, 2011 | -2.70 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Mar 31, 2011 | -144,313.00 |
| Dec 31, 2010 | -2.84 Mn |
| Sep 30, 2010 | -1.44 Mn |